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Abstract 
 
Background: Current chemotherapeutic agents for the treatment of African trypanosomiasis have become largely 
ineffective, necessitating the search for alternative compounds. The objective of this study was to evaluate in vitro anti-
trypanosomal activities of methanol extracts of parts of Azadirachta indica against Trypanosoma brucei rhodesiense, 
Trypanosoma brucei brucei and Trypanosoma evansi and establish the in vivo efficacy of the most active extract.  
Materials and methods: Maceration of powdered leaves, stem bark and root bark of the plant in methanol afforded three 
extracts. In vitro assays were carried out with the extracts on the three trypanosome strains in 96-well microtitre plates at 
concentration ranges of 4000 - 1000µg/ml. The most active extract was assayed in vivo using Trypanosoma brucei 
rhodesiense infected Swiss albino mice at doses of 100, 200 and 400 mg/kg body weight. Melarsoprol and suramin served 
as positive controls. The infected untreated group served as the negative control. Parasitaemia levels, packed cell volume, 
body weight changes and mean survival period of all groups were monitored throughout the experimental period.  
Results: Methanol extract of the stem bark of A.indica was most active in vitro against all the three trypanosome strains 
(MIC values of 9.93±1.88, 16.25±0.92 and 9.97±0.44µg/ml for T. b. rhodesiense, T. b. brucei and T. evansi, respectively). 
The extract showed optimum activity at 400 mg/kg and was comparable to the positive control groups. Parasitaemia levels 
were kept at a significantly low level (p < 0.05) by the extract compared to the negative control. Notably, there was no 
significant difference (p>0.05) in mean survival time of mice treated with the extract at 400 mg/kg and the positive 
controls.  
Conclusion: In vitro and in vivo anti-trypanosomal activities of the methanol extract of A. indica stem bark could be 
attributed to the presence of constituents of moderate polarity.  
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Introduction 
 
African trypanosomiasis is caused by single-celled protozoa of the genus Trypanosoma. Trypanosoma brucei, T. b. 
gambiense and T. b. rhodesiense are the main causative agents of human African trypanosomiasis whereas animal African 
trypanosomiasis is caused by T. b. brucei, T. congolense, T. vivax, T. evansi and T. equiperdum (Brun, Hecker, & Lun, 
1998; Patrick et al., 2012; Swallow, 2000). African trypanosomiases impact negatively on the entire economy of Africa by 
weakening the health of both humans and animals (John, Rachid, Damian, Glyn, & Stephen, 2012). Parasite resistance to 
the existing chemotherapeutic agents compounded by the poor prospect for a vaccine due to antigenic variation of the 
parasite has spurred the search for alternative compounds for African trypanosomiasis (Florencia & Stefan, 2011).  
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However, there has been no significant resistance observed in clinical isolates and laboratory selection for some 
agents such as suramin. A possible explanation could lie in the fact that suramin unselectively inhibits enzymes and 
receptors, and therefore could inhibit multiple targets (Fairlamb, 2003). The current study aimed at investigating in vitro 
and in vivo anti-trypanosomal activities of methanol extracts of A. indica plant parts.  
Azadirachta indica has been used as traditional medicine for the management of various diseases for decades due 
to its medicinal properties (Brototi & Kaplay, 2011; Kumar, Debasis, Goutam, & Chandra, 2010). Extracts of A. indica 
have been reported to exhibit various pharmacological activities (Kumar et al., 2010). In the current study, treatment of T. 
b. rhodesiense infected Swiss white mice with the methanol extract of A. indica stem bark revealed that the extract was 
efficacious at a dose level of 400 mg/kg. 
 
Materials and Methods 
Plant collection and extraction 
 
Leaves, stem- and root-barks of A. indica were collected from Pwani University (Kilifi, North coast of Kenya). 
The plant species was identified by a taxonomist and a voucher specimen (Specimen No. EN/05/2012) deposited at the 
herbarium of the department of Pharmacy & Complementary/ Alternative Medicine, Kenyatta University and also at the 
East African Herbarium, National Museums of Kenya, Nairobi. The air dried plant parts were ground into fine powders 
followed by extraction at room temperature by maceration for 24 hours in methanol. The extracts were partitioned between 
water and dichloromethane (DCM). The DCM phases were combined and concentrated in vacuo. 
   
Trypanosomes  
 
Cryopreserved stabilates of Trypanosoma b. rhodesiense (KETRI 3438), T. b. brucei (EATRO 2400) and T. evansi 
(KETRI 2454) were obtained from the Biotechnology Research Institute, Kenya Agricultural and Livestock Research 
Organization, (KALRO) trypanosome bank. The stabilates were thawed at room temperature, suspended in cold phosphate-
saline-glucose (PSG) buffer pH 8.0 and injected intraperitonially into immunosuppressed donor mice for multiplication. At 
the first peak of parasitaemia, donor mice were anaesthetized using carbon dioxide and blood collected from the heart of the 
mice using a syringe containing ethylene diamine tetra acetic acid (EDTA) as anticoagulant. The parasitaemia count was 
quantified using a haemocytometer and the blood was diluted appropriately with PSG buffer to obtain the required 
inoculum dose of 1×104 trypanosomes/ml.  
 
In vitro assays for anti-trypanosomal activity 
 
The in vitro antitrypanosomal assays were carried out in 96-well microtitre plates according to the method by Räz 
et al., (1997).  The first stock solutions of the extracts were prepared in distilled water for the water-soluble samples at 20 
mg/ml or in dimethyl sulfoxide (DMSO) (at 1 mg/100 µl) for the water-insoluble samples. The extracts were assayed on the 
three trypanosome strains at concentration ranges of 4000 - 1000µg/ml. Each plate was examined with an inverted 
microscope to determine the minimum inhibitory concentration (MIC) which is the concentration at which no cell with a 
normal morphology and/or motility was found in comparison to the negative control cultures (Githua et al., 2010).  
 
Experimental animals 
 
Randomly selected healthy female Swiss white mice weighing between 20 - 25 g were obtained from 
Biotechnology Research Institute, KALRO small animal breeding unit. They were dewormed using injectable ivermectin at 
0.1ml per mouse and were acclimatized for 14 days during which they were maintained on a diet of commercial mice 
pellets (mice pellets®, Unga Ltd, Nairobi, Kenya) and water was provided ad libitum. All experimental protocols and 
procedures used on animals during the study were reviewed and approved by the Institutional Animal Care and Use 
Committee (IACUC) of Biotechnology Research Institute, KALRO. 
 
Determination of acute toxicity 
 
Twenty mice were randomly placed into four groups of five animals each. Each group received treatment of the 
following doses of the methanol extract of the stem bark intraperitoneally, daily for four days: Group i (100 mg/kg body 
weight (bwt); Group ii (200 mg/kg bwt); and Group iii (400 mg/kg bwt). Group iv was given water only. Animals were 
initially observed closely for a period of 10-15 minutes following administration of the test drug for signs of acute toxicity. 
The mice were then closely monitored throughout the 4 days of administration and two weeks of experiment. Changes in 
posture, breathing, food intake and water consumption patterns of the treated mice were noted on a daily basis. Excessive  
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weight loss and changes of packed cell volume (PCV) of more than two-fold compared with the control group of mice over 
the 2 weeks period was considered a key indicator of declining health due to drug toxicity (Mbaya, Ibrahim, God, & Ladi, 
2010). 
 
Determination of in vivo efficacy  
 
Thirty five mice were randomly divided into seven groups of five mice each. Each experimental mouse was 
intraperitonially injected 0.2 ml of PSG buffer containing an inoculum dose of 1×104 trypanosomes/ml of T. b. rhodesiense 
(KETRI 3438) from donor mice. The mice were then treated as follows: Group i; i.p. treatment of  100 mg/kg bwt of 
extract, 24 hours post-infection (PI) for four days; Group ii ; i.p. treatment with 200 mg/kg bwt of extract from 24 hours PI 
for four days; Group iii; i.p. treatment with 400 mg/kg bwt of extract from 24 hours PI for four days; Group iv; 
intraperitoneally treated using suramin (5 mg/kg bwt) from 24 hours PI for three days (positive control I), Group v; 
intraperitoneally treated using melarsoprol (3.6 mg/ml) from 24 hours PI for three days (positive control II), Group vi; 
infected and given water ad-libitum with no extract (negative control), Group vii; uninfected and untreated (blank group). 
Group vii was included in the study for purposes of reference especially on the survival of the mice throughout the 
experimental period (60 days). Determination of in vivo efficacy was based on the changes in the levels of parasitaemia, 
packed cell volume (PCV) and weights of the animals during the experimental period.  
 
 
Parasitaemia examination  
 
The level of parasitaemia was determined daily for five days after the first treatment, then every two days for the 
remaining days of the experimental period. A drop of blood was collected from the mouse tail, placed on a clean slide, 
covered with a cover slip and viewed under the microscope at x400 magnification using the method of Herbert and 
Lumsden (1976).  
 
Determination of packed cell volume (PCV)   
 
Packed cell volume (PCV) was determined by bleeding tail vein of mice and filling three-quarters full heparinized 
capillary tubes with 50-60 µl of the blood. The sealed tubes were centrifuged at 10000 rpm for 5 minutes in a haematocrit 
centrifuge, and the height of the red blood cell column was measured by use of haematocrit reader. The percentage of the 
total blood volume occupied by red blood cell mass was considered as the PCV. 
 
Mean Survival Time  
 
The survival time for each mouse was recorded by daily checking the cages for mortality. The number of dead 
mice was recorded throughout the experimental period. The average survival time was then calculated. 
 
Data Analysis  
Statistical Package for Social Science (SPSS) version 21 was used for data analysis and the values obtained were 
expressed as mean ± standard error of mean (SE). The significant differences between variables were compared by one-way 
ANOVA followed by Student Newmann Keul’s test (SNK).  P values less than 0.05 were considered significant. 
 
Results 
 
The in vitro activities were classified according to Hoet et al.(Hoet et al., 2004). It emerged that the stem bark 
extract was the most active exhibiting anti-trypanosomal effects against all the three strains used in the study (Table 1).  
 
Table 1: In vitro anti-trypanosomal activity (MIC) of methanol extracts of A. indica 
Plant Part/ MIC ± SE (µg/ml) against 
Compound T. b. rhodesiense T. b. brucei T. evansi 
Leaf 51.98±1.21 48.17±0.11 22.13±0.14 
Stem bark 9.93±1.88 16.25±0.92 9.97±0.44 
Root bark 23.50±0.07 18.38±0.25 32.70±0.09 
Melarsoprol 0.003 ± 0.001 0.005 ± 0.002 0.003 ± 0.001 
Suramin 1.54 ± 0.09 1.66 ± 0.10 1.51 ± 0.13 
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Acute toxicity studies 
 
No animal mortality was observed during the 14 days of experimentation. There were no visible signs of acute 
toxicity among the animals treated with the extract at the doses used in the study. 
 
Effect of the methanol extract of A. indica on parasitemia of T. b. rhodesiense infected mice 
 
There was a delay in the commencement of parasite appearance in the extract treated groups (Table 2). The 
optimum activity of the extract was obtained at 400 mg/kg, at which there was no significant difference (p>0.05) with 
positive control groups. Compared with the negative control, the 400 mg/kg extract kept parasitaemia at a significantly low 
level (p < 0.05) throughout the experimental period.  
 
Table 2: Effect of methanol extract of A. indica stem-bark on parasitemia of T. b. rhodesiense (KETRI 3438) infected mice 
Values are mean ± SEM; SE = standard error; n = 5; D = day; Mel = melarsoprol; Sur = suramin; negative control
= infected untreateated;  implies that mice were dead; values with the same superscript(s) down the column do
not differ significantly at p 0.05
Negative control 6.601.66b 8.340.11b 8.640.29c 8.480.28c 8.550.28c 9.000.00c  
5 mg/kg Sur 0.000.00a 0.000.00a 0.000.00a 0.000.00a 0.000.00a 0.000.00a 0.000.00a 0.000.00a
3.6 mg/kg Mel 0.000.00a 0.000.00a 0.000.00a 0.000.00a 0.000.00a 0.000.00a 0.000.00a 0.000.00a
400 mg/kg 0.000.00a 1.620.32a 1.620.32ab 1.380.14ab1.680.80ab 1.740.41ab1.800.18ab 1.740.41ab
200 mg/kg 2.881.62ab 4.441.82ab 5.042.07b 5.101.09bc5.082.16bc 3.001.07b 2.800.80b 3.001.07bc
100 mg/kg 3.901.76ab 6.481.64b 6.001.62bc 6.721.71c 6.961.75c 5.901.75b 5.401.29c 4.801.96c
D7 D14 D21 D28 D35 D42 D49 D56
Treatment
group
Parasitemia level (log number)/mL
 
 
Effect of extract on packed cell volume of T. b. rhodesiense infected mice 
 
There was no significant difference in maintaining the PCV values  in the animals treated with the extract at 400 
mg/kg and the positive control groups (melarsoprol and suramin) throughout the study period (p >0.05). Packed cell 
volume (PCV) values in the negative control group started declining and remained lower than the values of the extract 
treated groups (Table 3). 
 
Table 3: Effect of methanol extract of A. indica stem-bark on packed cell volume of T. b. rhodesiense (KETRI 3438) 
infected mice 
43.001.34a
52.600.51b
51.801.21b
49.601.81ab
45.602.20ab
45.402.73ab
D14
Packed cell volume (PCV(%)) of mice
D56

54.600.75c
52.800.37c
51.201.84bc
50.672.21bc
45.334.11a
D49
37.50±2.21a
55.200.73b
54.800.49b
50.402.75b
51.003.22b
48.333.61b
D42
39.672.85a
53.200.86b
52.800.86b
50.002.35b
46.202.87ab
43.003.30ab
D35
40.754.96a
52.201.16b
53.600.80b
50.400.81b
50.201.11b
43.802.99ab
D28
42.001.76a
51.400.51b
53.200.37b
48.801.24ab
48.602.23ab
44.204.47ab
D21D7
Values are mean ± SE; SE = standard error; n = 5; D = day; Mel = melarsoprol; Sur = suramin; negative control = infected
untreateated; implies that mice were dead; values with the same superscript(s) down the column do not differ significantly
at p 0.05
Negative control
5 mg/kg Sur
3.6 mg/kg Mel
400 mg/kg
200 mg/kg
100mg/kg
Treatment
group

53.80±0.80b
52.90±0.58b
51.001.10ab
49.673.39a
48.000.00a
47.401.03a
52.001.05b
52.401.69b
50.001.24ab
49.801.87a
47.000.71a
 
 
Effect of stem-bark extract of A. indica on body weight of T. b. rhodesiense infected mice 
 
At the optimum dose of 400 mg/kg the extract treated animals and positive control groups showed comparable 
increment in body weight (Figure 1).  
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Figure 1: Trends of percentage (%) change in body weight of T. b. rhodesiense (KETRI 3438) infected mice treated 
intraperitoneally with methanol extract of A. indica stem bark; values are mean ± SE; n = 5; negative control = infected 
untreated; Mel = melarsoprol; Sur = suramin 
 
Effect on mean survival time of T. b. rhodesiense infected mice 
 
Animals treated with the extract at various dose levels survived for longer time compared to the infected-untreated 
control (33.00±3.08 days). The survival times between the extract treated animals at higher doses (200 and 400 mg/kg) 
differed significantly with the negative control group. The mean survival time of animals treated with the extract at 400 
mg/kg was comparable to those in positive control groups.  
 
Table 4: Effect of methanol extract of A. indica stem-bark on mean survival time of T. b. rhodesiense (KETRI 3438) 
infected mice 
Treatment 
group 
Number of mice Percentage of 
mice cured 
Mean survival 
time (days ± SE) treated survived cured 
100 mg/kg 5 1 0 0 46.2±5.44ab 
200 mg/kg 5 3 1 20 51.8±5.14bc 
400 mg/kg 5 5 4 80 59.6±0.40c 
3.6 mg/kg Mel 5 5 5 100 60.0±0.00c 
5 mg/kg Sur 5 5 5 100 60.0±0.00c 
Negative control 5 0 0 0 33.0±3.08a 
Blank 5 5 5 100 60.0±0.00c 
SE = standard error; Mel = melarsoprol; Sur = suramin; negative control = infected untreated; blank = uninfected untreated; 
values with the same superscript(s) do not differ significantly at p<0.05. 
 
Discussion  
 
Anti-trypanosomal activity of A. indica reported in the present study is comparable to a report by Mbaya et al. 
(Mbaya et al., 2010) which showed that A. indica stem bark possesses in vitro trypanocidal effect against T. b. brucei. A 
study on the leaf extract of A. indica by Githua et al. (2010) showed that the extract was active in vitro against procyclic 
forms of T. b. rhodesiense.  
Results from in vivo efficacy study indicated that at a higher dose of 400 mg/kg, the methanol extract of A. indica 
stem bark maintained parasitaemia in T. b. rhodesiense infected mice at significantly lower levels as compared to the 
negative control indicating the presence of anti-trypanosomal constituents in the extract. However, a steady rise in 
parasitaemia levels was observed in animals treated with the extract at lower doses of 100 and 200 mg/kg from D14 to D56, 
indicating that the ability of the extract to control parasitaemia levels of infected mice was dose-dependent.  A similar trend 
was observed in the ability of the extract to extend survival period of infected mice. These observations demonstrate that 
the anti-trypanosomal activity of the extract could be improved by using a higher dose or isolated active compounds in the 
extract.  
The extract significantly reduced weight loss and decline in packed cell volume (PCV) associated with 
parasitaemia. Packed cell volume and weight loss are common and critical features in the pathogenesis of African 
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 trypanosomiasis contributing to morbidity and mortality (Kagira, Thuita, & Ngotho, 2006). Infected mice treated with A. 
indica extract in the current study showed significantly higher levels in PCV compared to the negative control (infected 
untreated) group which can be ascribed to an enhanced resistance of erythrocyte haemolysis (Kagira et al., 2006).  
These findings are in agreement with a previous study which reported that A. indica exhibited encouraging in vivo 
trypanocidal activity with a reduction in the level of T. brucei parasitemia in mice (Mbaya et al., 2010). A similar study 
(Ngure et al., 2009) revealed that the aqueous extract of Azadirachta indica was active against Trypanosoma brucei 
rhodesiense, indicating that polar constituents of the stem bark could be contributing to the antitrypanosomal effects of the 
plant part.  
 
Conclusion 
 
The current study established that the methanol extract of A. indica stem bark possess both in vitro and in vivo 
antitrypanosomal activity against T. brucei rhodesiense. Isolation and characterization of constituents of the extract, which 
is currently on-going research, could yield a potential antitrypanosomal lead compound. 
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